7Baggers

We provide you with 20 years of free, institutional-grade data for CERT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CERT. Explore the full financial landscape of CERT stock.

Reported DateCIKTickerType
2025-08-060001827090CERT10-QUrl
2025-05-050001827090CERT10-QUrl
2025-02-260001827090CERT10-KUrl
2024-11-060001827090CERT10-QUrl
2024-08-060001827090CERT10-QUrl
2024-05-070001827090CERT10-QUrl
2024-02-290001827090CERT10-KUrl
2023-11-080001827090CERT10-QUrl
2023-08-090001827090CERT10-QUrl
2023-05-080001827090CERT10-QUrl
2023-03-010001827090CERT10-KUrl
2022-11-070001827090CERT10-QUrl
2022-08-090001827090CERT10-QUrl
2022-05-050001827090CERT10-QUrl
2022-03-010001827090CERT10-KUrl
2021-11-150001827090CERTS-1Url
2021-11-090001827090CERT10-QUrl
2021-09-030001827090CERTS-1Url
2021-08-060001827090CERT10-QUrl
2021-05-070001827090CERT10-QUrl
2021-03-220001827090CERTS-1Url
2021-03-150001827090CERT10-KUrl
2020-11-180001827090CERTS-1Url

Certara, Inc
(NASDAQ:CERT) 

CERT stock logo

Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug disco...

Founded: 2008
CEO: William F. Feehery Ph.D.  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about CERT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.